Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0YY2W
|
|||
| Former ID |
DNC011211
|
|||
| Drug Name |
1-phenyl-3-(1,3,4-thiadiazol-2-yl)thiourea
|
|||
| Synonyms |
1-phenyl-3-(1,3,4-thiadiazol-2-yl)thiourea; CHEMBL1253381; AC1LHWR1; SCHEMBL13779380; MolPort-002-153-004; ZINC436272; BDBM50326573; AKOS000986880; MCULE-5997854144; SDCCGMLS-0064737.P001; ST50980881; AB00086777-01; SR-01000210707; SR-01000210707-1; Z56753795; (phenylamino)(1,3,4-thiadiazol-2-ylamino)methane-1-thione
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C9H8N4S2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)NC(=S)NC2=NN=CS2
|
|||
| InChI |
1S/C9H8N4S2/c14-8(12-9-13-10-6-15-9)11-7-4-2-1-3-5-7/h1-6H,(H2,11,12,13,14)
|
|||
| InChIKey |
CSUHGRXUQXQHRB-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | MIF messenger RNA (MIF mRNA) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Tyrosine metabolism | |||
| Phenylalanine metabolism | ||||
| Pathwhiz Pathway | Tyrosine Metabolism | |||
| WikiPathways | Spinal Cord Injury | |||
| Adipogenesis | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem. 2010 Jul 15;18(14):5425-40. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.